Understanding how to improve acceptance of personalized cancer risk information
Understanding and addressing rejection of personalized cancer risk information
This study is all about helping women understand their personal risk for breast cancer so they can make better choices about when to start screening, making sure the information is clear and helpful for everyone.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Colorado Denver NIH-funded |
| Lab location | 1 site (Aurora, UNITED STATES) |
| Project ID | NIH-10891606 on NIH RePORTER |
What this research studies
This research focuses on enhancing the way personalized cancer risk information is communicated to patients, particularly regarding breast cancer screening. It aims to identify barriers that prevent women from making informed decisions about when to start screening based on their individual risk factors. By utilizing cancer risk prediction models, the study seeks to tailor screening recommendations to maximize benefits and minimize potential harms. The approach includes assessing how well patients comprehend their risk and the implications for their screening choices.
Who could benefit from this research
Good fit: Ideal candidates for this research include women aged 40-49 who are considering breast cancer screening and have varying levels of personal risk factors.
Not a fit: Patients who are not eligible for breast cancer screening or those who have already made informed decisions about their screening may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective cancer screening practices that are better tailored to individual risk, ultimately improving patient outcomes.
How similar studies have performed: Previous research has shown that personalized risk communication can improve patient decision-making in cancer screening, indicating a promising approach.
Where this research is happening
Aurora, UNITED STATES
- University of Colorado Denver — Aurora, United States (Active)
Researchers
- Principal investigator: Scherer, Laura D. — University of Colorado Denver
- Study coordinator: Scherer, Laura D.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.